Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,302
datasets available to search
ShareScore release 0.9.0
Dataset results
2,302 results for “B-cells”
Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00294632. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02142049. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2
ClinicalTrials.gov study NCT01724021. IPD Sharing: Not stated. Countries: 32. Publications: 2.
Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT04261790. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT01282424. IPD Sharing: YES. Countries: 6. Publications: 3.
A Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-A33/KEYNOTE-A33)
ClinicalTrials.gov study NCT04317066. IPD Sharing: YES. Countries: 1. Publications: 1.
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
ClinicalTrials.gov study NCT03744676. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01649856. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03589469. IPD Sharing: NO. Countries: 4. Publications: 7.
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lym
ClinicalTrials.gov study NCT02951156. IPD Sharing: YES. Countries: 8. Publications: 1.
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
ClinicalTrials.gov study NCT06004167. IPD Sharing: YES. Countries: 1. Publications: 1.
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02953509. IPD Sharing: NO. Countries: 3. Publications: 4.
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01092182. IPD Sharing: YES. Countries: 1. Publications: 2.
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
ClinicalTrials.gov study NCT02367040. IPD Sharing: NO. Countries: 37. Publications: 2.
Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00193479. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00118209. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma
ClinicalTrials.gov study NCT03189524. IPD Sharing: YES. Countries: 1. Publications: 3.
Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts
ClinicalTrials.gov study NCT03160079. IPD Sharing: NO. Countries: 1. Publications: 9.
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
ClinicalTrials.gov study NCT00577278. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies
ClinicalTrials.gov study NCT02343120. IPD Sharing: Not stated. Countries: 6. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.